Literature DB >> 25692622

A new vaccine escape mutant of hepatitis B virus causes occult infection.

Qing Ye1, Shi-Qiang Shang, Wei Li.   

Abstract

There is growing public concern regarding assay sensitivity to HBsAg mutants in clinical diagnosis and vaccine escape. The aim of this study is to introduce a new HBsAg mutant strain. The serum samples were those of patient X at the age of 3 months and 3 years respectively, and of her mother immediately before parturition, which were used to amplify the HBsAg-coding DNA fragments by PCR. The HBsAg DNA sequences were translated into their corresponding amino acid sequences and then aligned in pubmed with nucleotide blast. The sequencing data of S coding regions shows that patient X has been infected by a new HBV variant with an A to C substitution at nt431, resulting in an Asp(GAC)to Ala(GCC) substitution at aa144 of major protein; CC to AA substitution at nt359 and nt360, resulting in an Pro(CCC) to Gln(CAA) substitution at aa120 of pre "a" epitope; A to G substitution at nt491, resulting in an Glu(GAG) to Gly(GGG) substitution at aa164 of post "a" epitope. Three new mutations (S171F, S174N and Q181R) at the antigenic epitopes of HBV presented by HLA class I molecules are found. The HBV mutant strain causes vaccine escape and occult infection.

Entities:  

Keywords:  ALP, alkaline phosphatase; ALT, alanine aminotransferase; AST, aspartate aminotransferase; AchE, acetylcholin esterase; Alb, albumin; Anti-HBc, antibodies to hepatitis B core antigen; Anti-HBs, antibodies to HBsAg; CMV, cytomegalovirus; CRP, C-reactive protein; EBNA, Epstein-Barr nuclear antigen; EBV, Epstein-Barr virus; EIA, enzyme immunoassay; HBV; HBsAg, hepatitis B surface antigen; HCV, hepatitis C virus; Hb, hemoglobin; LDH, lactate dehydrogenase; Plt, platelet count; RBC, red blood cell count; T-Bil, total bilirubin; TG, triglycerides; TP, total protein; UA, uric acid; VCA, viral capsid antigen; WBC, white blood cell count; anti-HA, antibody to hepatitis A; gene mutation; occult infection; vaccine escape; γGTP, γ-glutamyl transferase

Mesh:

Substances:

Year:  2015        PMID: 25692622      PMCID: PMC4514362          DOI: 10.4161/21645515.2014.994461

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  24 in total

Review 1.  Hepatitis B virus infection.

Authors:  W M Lee
Journal:  N Engl J Med       Date:  1997-12-11       Impact factor: 91.245

2.  Seroprevalence of hepatitis B and immune response to hepatitis B vaccination in Chinese college students mainly from the rural areas of western China and born before HBV vaccination integrated into expanded program of immunization.

Authors:  Xue-Yan Liao; Zhen-Zuo Zhou; Fu-Bang Wei; Han-Ning Qin; Yuan Ling; Rong-Cheng Li; Yan-Ping Li; Yi Nong; Kui-Xia Sun; Jie Li; Hui Zhuang
Journal:  Hum Vaccin Immunother       Date:  2013-09-09       Impact factor: 3.452

3.  Evaluation of a new automated assay for hepatitis B surface antigen (HBsAg) detection VIDAS HBsAg Ultra.

Authors:  Bernard Weber; Natacha Van der Taelem-Brulé; Annemarie Berger; François Simon; Marie Geudin; Jaques Ritter
Journal:  J Virol Methods       Date:  2006-03-29       Impact factor: 2.014

4.  European collaborative evaluation of the Enzygnost HBsAg 6.0 assay: performance on hepatitis B virus surface antigen variants.

Authors:  Ana Avellón; José M Echevarría; Bernard Weber; Michael Weik; Uwe Schobel; Wulf R Willems; Wolfram H Gerlich
Journal:  J Med Virol       Date:  2011-01       Impact factor: 2.327

5.  Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells.

Authors:  A Bertoletti; A Sette; F V Chisari; A Penna; M Levrero; M De Carli; F Fiaccadori; C Ferrari
Journal:  Nature       Date:  1994-06-02       Impact factor: 49.962

6.  Performance evaluation of 70 hepatitis B virus (HBV) surface antigen (HBsAg) assays from around the world by a geographically diverse panel with an array of HBV genotypes and HBsAg subtypes.

Authors:  H Scheiblauer; M El-Nageh; S Diaz; S Nick; H Zeichhardt; H-P Grunert; A Prince
Journal:  Vox Sang       Date:  2009-11-03       Impact factor: 2.144

7.  Breaking tolerance in hepatitis B surface antigen (HBsAg) transgenic mice by vaccination with cross-reactive, natural HBsAg variants.

Authors:  Reinhold Schirmbeck; Nektarios Dikopoulos; Marcin Kwissa; Frank Leithäuser; Kasper Lamberth; Soren Buus; Karl Melber; Jörg Reimann
Journal:  Eur J Immunol       Date:  2003-12       Impact factor: 5.532

8.  [Subgenotype and serotype analysis of hepatitis B virus in Korean chronic hepatitis B patients under treatment].

Authors:  Choong-Hwan Cha; Yong-Hak Sohn; Sun-Young Ko; Heung-Bum Oh
Journal:  Korean J Lab Med       Date:  2009-02

9.  Selective expansion of cytotoxic T lymphocytes with a CD4+CD56+ surface phenotype and a T helper type 1 profile of cytokine secretion in the liver of patients chronically infected with Hepatitis B virus.

Authors:  V Barnaba; A Franco; M Paroli; R Benvenuto; G De Petrillo; V L Burgio; I Santilio; C Balsano; M S Bonavita; G Cappelli
Journal:  J Immunol       Date:  1994-03-15       Impact factor: 5.422

Review 10.  T cell recognition of hepatitis B and C viral antigens.

Authors:  M C Jung; H M Diepolder; G R Pape
Journal:  Eur J Clin Invest       Date:  1994-10       Impact factor: 4.686

View more
  10 in total

1.  Effects of amino acid substitutions in hepatitis B virus surface protein on virion secretion, antigenicity, HBsAg and viral DNA.

Authors:  Kuan-Hui Xiang; Eleftherios Michailidis; Hai Ding; Ya-Qin Peng; Ming-Ze Su; Yao Li; Xue-En Liu; Viet Loan Dao Thi; Xian-Fang Wu; William M Schneider; Charles M Rice; Hui Zhuang; Tong Li
Journal:  J Hepatol       Date:  2016-09-17       Impact factor: 25.083

2.  Investigation of a Novel Hepatitis B Virus Surface Antigen (HBsAg) Escape Mutant Affecting Immunogenicity.

Authors:  Md Golzar Hossain; Keiji Ueda
Journal:  PLoS One       Date:  2017-01-03       Impact factor: 3.240

3.  Clinical features and viral quasispecies characteristics associated with infection by the hepatitis B virus G145R immune escape mutant.

Authors:  Yuan Xue; Ming-Jie Wang; Zhi-Tao Yang; De-Min Yu; Yue Han; Dao Huang; Dong-Hua Zhang; Xin-Xin Zhang
Journal:  Emerg Microbes Infect       Date:  2017-03-22       Impact factor: 7.163

Review 4.  Hepatitis B Virus Adaptation to the CD8+ T Cell Response: Consequences for Host and Pathogen.

Authors:  Sheila F Lumley; Anna L McNaughton; Paul Klenerman; Katrina A Lythgoe; Philippa C Matthews
Journal:  Front Immunol       Date:  2018-07-16       Impact factor: 7.561

Review 5.  Hepatitis B virus infection: Defective surface antigen expression and pathogenesis.

Authors:  Chun-Chen Wu; Ying-Shan Chen; Liang Cao; Xin-Wen Chen; Meng-Ji Lu
Journal:  World J Gastroenterol       Date:  2018-08-21       Impact factor: 5.742

6.  Patterns of hepatitis B virus S gene escape mutants and reverse transcriptase mutations among genotype D isolates in Jordan.

Authors:  Nidaa A Ababneh; Malik Sallam; Doaa Kaddomi; Abdelrahman M Attili; Isam Bsisu; Nadia Khamees; Amer Khatib; Azmi Mahafzah
Journal:  PeerJ       Date:  2019-03-08       Impact factor: 2.984

Review 7.  Hepatitis B and Pregnancy: Virologic and Immunologic Characteristics.

Authors:  Shivali S Joshi; Carla S Coffin
Journal:  Hepatol Commun       Date:  2020-01-02

8.  Characterization of Novel Hepatitis B Virus PreS/S-Gene Mutations in a Patient with Occult Hepatitis B Virus Infection.

Authors:  Jianhong Chen; Yan Liu; Jun Zhao; Zhihui Xu; Rongjuan Chen; Lanlan Si; Shanshan Lu; Xiaodong Li; Shuai Wang; Kai Zhang; Jin Li; Juqiang Han; Dongping Xu
Journal:  PLoS One       Date:  2016-05-16       Impact factor: 3.240

9.  Reactivation of a Vaccine Escape Hepatitis B Virus Mutant in a Cambodian Patient During Anti-Hepatitis C Virus Therapy.

Authors:  Dahlene N Fusco; Lilia Ganova-Raeva; Yury Khudyakov; Lili Punkova; Aisha Mohamed; Scarlett Se Yun Cheon; Prapti Koirala; Karin L Andersson; Gonzague Jourdain; Camille Sureau; Raymond T Chung; Georg Lauer
Journal:  Front Med (Lausanne)       Date:  2018-04-30

10.  Computational Design of a Novel VLP-Based Vaccine for Hepatitis B Virus.

Authors:  Saeed Mobini; Milad Chizari; Ladan Mafakher; Elmira Rismani; Elham Rismani
Journal:  Front Immunol       Date:  2020-08-27       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.